No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human PKC eta Antibodies:
anti-Mouse (Murine) PKC eta Antibodies:
anti-Rat (Rattus) PKC eta Antibodies:
Go to our pre-filtered search.
Human Polyclonal PKC eta Primary Antibody for WB - ABIN3043361
Gan, Wang, Zhao, Wu, Yang, Peng: 5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors. in Drug design, development and therapy 2016
These results suggest that PKCeta utilizes the ERK signaling pathway to protect against ubiquitin-mediated proteasomal degradation of Mcl-1
PRKCH rs2230500 gene polymorphism is significantly related to the efficiency in telmisartan therapy (p = 0.02). The PRKCH rs2230500 may influence the antihypertensive efficacy of telmisartan in Chinese EH patients.
PRKCH is highly expressed in hematopoietic stem cell (HSC) and is necessary for optimal HSC function.
The association between PRKCH 1425G/A and lacunar infarction was independent of traditional stroke risk factors
Data suggest that targeted manipulation of protein kinase C isoforms PKCalpha, PKCbeta, and PKCeta might be beneficial in certain proteinuric kidney diseases with altered transient receptor potential cation channel subfamily C member 6 protein (TRPC6) functions.
variant genotypes of PRKCH 1425G/A are an independent prognostic factor for ischemic stroke in the final multivariate Cox regression model
Meta-analysis indicated that the 1425G/A SNP in PRKCH may contribute to susceptibility of stroke, especially for ischemic stroke.
PKCeta promotes senescence through its ability to upregulate the expression of the cell cycle inhibitors p21Cip1 and p27Kip1 and enhance transcription and secretion of IL-6.
The 1425G/A polymorphism in PRKCH is not a significant predictor of stroke recurrence in patients with acute ischemic stroke during a 2-year follow-up period.
PKC-eta associates with NHE3 and gamma tubulin to promote the cell polarity during migration.
These results suggest that siRNA-mediated silencing of PKCeta can be a potent tool to complement existing chemotherapy regimens for treating EBV(+) B lymphoma.
the PKC family genes may play a role in the pathogenesis of MS relapse through modulating the association between 25(OH)D and relapse.
Upregulation of PKCeta contributes to breast cancer cell growth and targeting either PKCepsilon or PDK1 triggers PKCeta downregulation
study demonstrates that type V collagen induces the down-regulation of protein kinase C eta
these results suggest that the regulation of PKCeta is unique and PKCepsilon is required for the PKC activator-induced upregulation of PKCeta.
The single nucleotide polymorphism (rs2230500) in PRKCH decreases the risk of carotid intima-media thickness.
There was loss of the negative correlation in the expression levels of CD3eta and FcepsilonRIgamma genes in CLL patients.
Protein kinase Ceta 1425G/A variant was not a risk locus for deep intracerebral hemorrhage phenotype.
It was shown that the PKCeta isoform is a negative regulator of the AKT signaling pathway. The IGF-I induced phosphorylation on Ser473 of AKT was inhibited by the PKCeta-induced expression in MCF-7 breast adenocarcinoma cancer cells.
A remarkable association of minor alleles (1425G/A and _15) in the PRKCH gene with an elevated risk of coronary artery disease and increased levels of LDL-C in a Chinese population.
genetic deficiency results in defective suppressive activity of T reg cells
data suggest that PKCeta shares some redundant roles with PKCtheta; in T cell biology and also performs nonredundant functions that are required for T cell homeostasis and activation
Protein kinase C eta promotes a proliferation to differentiation switch in keratinocytes via upregulation of p27Kip1 mRNA through suppression of JNK/c-Jun signaling under stress conditions.
these results establish a previously uncharacterized role forPKC-epsilon, PKC-eta, PKC-theta in T cell polarity.
ATP1A1 interaction with PKCeta and occludin was involved in the integrity of the blood-labyrinth-barrier
PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation
The expression of specific PKC isotypes was significantly changed as embryonic stem cells differentiated into cardiomyocytes.
Parvovirus infection was found to result in activation of both PDK1 and PKCeta, as evidenced by changes in their subcellular distribution and overall (auto)phosphorylation.
directs the induction of IRF-4 expression downstream of BLNK in the pre-BCR signaling pathway promoting kappa gene rearrangement
nPKCeta positively regulates agonist-induced thromboxane generation with no effects on platelet aggregation.
Translational regulation could provide an additional level for controlling the expression of PKC family members.
Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role in cells. The protein encoded by this gene is one of the PKC family members. It is a calcium-independent and phospholipids-dependent protein kinase. It is predominantly expressed in epithelial tissues and has been shown to reside specifically in the cell nucleus. This protein kinase can regulate keratinocyte differentiation by activating the MAP kinase MAPK13 (p38delta)-activated protein kinase cascade that targets CCAAT/enhancer-binding protein alpha (CEBPA). It is also found to mediate the transcription activation of the transglutaminase 1 (TGM1) gene.
protein kinase C eta type
, protein kinase C-eta
, protein kinase C, eta
, protein kinase C eta type-like
, LOW QUALITY PROTEIN: protein kinase C eta type